SCHEDULE: BlackRock Discloses 4.8% Stake in Biophytis SA
Ownership Disclosure
BlackRock Portfolio Management LLC has reported a 4.8% beneficial ownership in Biophytis SA common stock as of December 31, 2025.
Summary
- BlackRock Portfolio Management LLC holds 1,905,946 shares of Biophytis SA common stock.
- This ownership represents 4.8% of Biophytis SA's total outstanding common stock.
- BlackRock Portfolio Management LLC exercises sole voting and dispositive power over these shares.
- KREOS CAPITAL GROUP VI LP is identified as another entity beneficially owning 5% or greater of Biophytis SA's outstanding shares.
- The statement is filed as an Amendment No. 1 to Schedule 13G, pursuant to Rule 13d-1(c).
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of institutional ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the issuer's performance or outlook.
Positives
- BlackRock Portfolio Management LLC maintains a significant institutional investment in Biophytis SA, holding 4.8% of common stock.
- The investment is held in the ordinary course of business and not for the purpose of changing or influencing control of Biophytis SA.
Future Outlook
No forward-looking statements or guidance regarding Biophytis SA's future performance or strategy are provided in this ownership disclosure.
Industry Context
This filing represents a routine disclosure of institutional ownership, common in the biotechnology and pharmaceutical sectors, where large asset managers like BlackRock frequently hold stakes in publicly traded companies. It provides transparency on significant shareholder positions.
Stakeholder Impact
- Shareholders gain transparency regarding a significant institutional investor's stake.
- The presence of a large institutional investor like BlackRock can signal confidence, though the 4.8% stake is below the 5% threshold for initial mandatory public disclosure.
Key Dates
| Date | Description |
|---|---|
| 2025-01-28 | Date of previously revoked Power of Attorney for BlackRock. |
| 2025-07-01 | Effective date of the new Power of Attorney for BlackRock. |
| 2025-12-31 | Date of event requiring the filing, reflecting BlackRock's ownership snapshot. |
| 2026-01-21 | Signature date of the Schedule 13G Amendment No. 1 filing. |
Keywords
Biophytis SA, BlackRock Portfolio Management LLC, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor, Biotechnology, Pharmaceuticals, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.